While there is no cure for AD, there are treatments that can help slow its progression when detected early enough. When the disease develops before the age of 65, it’s considered early-onset Alzheimer’s, which can begin as early as a person’s 30s, although this is rare. This ratio between these two molecular biomarkers may help to detect the risk of Alzheimer’s disease before severe mental decline.įor most people with Alzheimer’s disease - those who have the late-onset variety - symptoms first appear when someone is in their mid-60s or later. This Alzheimer’s test measures A-beta 42 and A-beta 40 biomarkers and provides the A-beta 42/40 blood levels ratio. had past diagnosed brain trauma or head injuryĪdditionally, if you are younger than 50 years old, this test may not be right for you.Īlzheimer’s disease (AD) is a progressive brain-related disorder that affects memory and understanding and can progress to complete mental and physical impairment.having a family history of Alzheimer’s disease.experiencing memory loss or early cognitive impairment or decline(trouble remembering, concentrating, making decisions, etc.).The following risk-factors are associated with a higher likelihood of developing Alzheimer’s disease: This blood screening test measures A-beta 42, A-beta 40, and provides the A-beta 42/40 ratio blood levels. and/or is experiencing memory loss or early cognitive decline (trouble remembering, concentrating, making decisions, etc.)Ī screening test is done to detect signs of, or risk factors for, health disorders in people who may or may not have symptoms of a specific disease.has had diagnosed brain trauma or a head injury.a genetic predisposition to Alzheimer’s disease.has a family history of Alzheimer’s disease.

The AD-Detect (Alzheimer’s disease) test is for anyone who suspects:

Find quest diagnostics locations